Tcw Group Inc Viking Therapeutics, Inc. Transaction History
Tcw Group Inc
- $10.4 Billion
- Q1 2025
A detailed history of Tcw Group Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Tcw Group Inc holds 75,054 shares of VKTX stock, worth $2.41 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
75,054
Previous 61,651
21.74%
Holding current value
$2.41 Million
Previous $2.48 Million
26.94%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
447Shares Held
65.4MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$193 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$130 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$100 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$100 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.46B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...